D.E. Shaw & Co’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.6M Buy
1,430,100
+497,000
+53% +$23.5M 0.03% 634
2025
Q4
$47.5M Buy
933,100
+716,500
+331% +$36.6M 0.03% 734
2025
Q3
$12M Buy
216,600
+94,000
+77% +$5.5M 0.01% 1536
2025
Q2
$8.46M Buy
122,600
+76,700
+167% +$5.22M 0.01% 1622
2025
Q1
$3.19M Sell
45,900
-59,900
-57% -$4.95M ﹤0.01% 2245
2024
Q4
$9.1M Buy
105,800
+15,300
+17% +$1.65M 0.01% 1567
2024
Q3
$10.8M Sell
90,500
-119,000
-57% -$15.9M 0.01% 1383
2024
Q2
$29.9M Buy
209,500
+186,500
+811% +$24.7M 0.03% 673
2024
Q1
$2.95M Sell
23,000
-11,500
-33% -$1.37M ﹤0.01% 2318
2023
Q4
$3.57M Buy
34,500
+31,100
+915% +$3.08M ﹤0.01% 2191
2023
Q3
$309K Hold
3,400
﹤0.01% 3600
2023
Q2
$275K Buy
+3,400
New +$278K ﹤0.01% 3629
2014
Q2
Sell
-52,800
Closed -$1.21M 4428
2014
Q1
$1.21M Buy
+52,800
New +$1.12M ﹤0.01% 2861
2013
Q3
Sell
-200,000
Closed -$3.1M 4404
2013
Q2
$3.1M Buy
+200,000
New +$3.33M 0.01% 1715

Other funds holding NVO